NCT00293384 arm group f3335a25d65a83e1ecc20d25a36e2afc [clinicaltrials_resource:NCT00293384/arm-group/f3335a25d65a83e1ecc20d25a36e2afc]
Aprepitant [clinicaltrials_resource:1d29a5d3c4b65994ae4f403acd0bb0b6]Granisetron hydrochloride [clinicaltrials_resource:3c91eb8c8f7a7ba6baf14e5ad97cd382]Cyclophosphamide [clinicaltrials_resource:addcaba682366522e86a8e0d2f77c987]Dexamethasone [clinicaltrials_resource:ccb8fc9fbc5e752bc816eb7c11d398a7]clinicaltrials:NCT00293384
arm group [clinicaltrials_vocabulary:arm-group]
NCT00293384 arm group f3335a25d65a83e1ecc20d25a36e2afc [clinicaltrials_resource:NCT00293384/arm-group/f3335a25d65a83e1ecc20d25a36e2afc]
Bio2RDF identifier
NCT00293384/arm-group/f3335a25d65a83e1ecc20d25a36e2afc
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 335a25d65a83e1ecc20d25a36e2afc
description [clinicaltrials_vocabulary:description]
Day 1: 1 mg of Kytril orally ...... mg once daily in the morning.
identifier
clinicaltrials_resource:NCT00293384/arm-group/f3335a25d65a83e1ecc20d25a36e2afc
title
NCT00293384 arm group f3335a25d65a83e1ecc20d25a36e2afc
@en
type
label
NCT00293384 arm group f3335a25 ...... 35a25d65a83e1ecc20d25a36e2afc]
@en